Related Experiment Video
Updated: Jun 24, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Antiplatelet drugs for ischemic stroke prevention
Didier Leys1, Clotilde Balucani, Charlotte Cordonnier
1Department of Neurology, Hôpital Roger Salengro, EA 2691, University Lille II, Lille, France. dleys@chru-lille.fr
Cerebrovascular Diseases (Basel, Switzerland)
|April 4, 2009
Summary
Aspirin offers a modest reduction in ischemic strokes for women and patients with nonvalvular atrial fibrillation (NVAF). However, warfarin is more effective for stroke prevention in specific high-risk NVAF patient groups.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Aspirin is widely used for stroke prevention, but its efficacy and safety vary across different patient populations and conditions.
- Nonvalvular atrial fibrillation (NVAF) presents unique challenges for stroke risk management.
- Understanding optimal antithrombotic strategies is crucial for both primary and secondary stroke prevention.
Purpose of the Study:
- To review the evidence on aspirin's effectiveness and safety in primary and secondary stroke prevention.
- To compare aspirin with other antithrombotic agents, including warfarin, clopidogrel, and aspirin plus extended-release dipyridamole.
- To evaluate aspirin's role in the acute stage of ischemic stroke.
Main Methods:
- Systematic review and meta-analysis of primary and secondary prevention trials.
- Comparative effectiveness analysis of different antithrombotic agents.
- Assessment of safety profiles, including gastrointestinal tolerance and bleeding risk.
Main Results:
- Aspirin shows a small benefit in ischemic stroke reduction for women in primary prevention and for NVAF patients.
- Warfarin is more effective than aspirin in high-risk NVAF patients (hypertension, LV dysfunction, age >75).
- In secondary prevention, aspirin reduces recurrent events, but higher doses (>150 mg) worsen GI tolerance; aspirin plus clopidogrel increases bleeding risk without added benefit.
Conclusions:
- Aspirin is a reasonable option for primary stroke prevention in low-risk women and for NVAF, though warfarin is superior in specific high-risk NVAF subgroups.
- For secondary stroke prevention, aspirin is effective, but alternative agents like clopidogrel or aspirin/dipyridamole may offer slight advantages; combination therapy with aspirin/clopidogrel is not recommended.
- Aspirin is safe and effective in the acute phase of ischemic stroke, including in NVAF patients.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.